SITC Immunotherapy for the Treatment of Advanced Renal Cell Carcinoma Guideline Pocket Guide Cover

Immunotherapy for Advanced Renal Cell Carcinoma GUIDELINES Pocket Guide

Approved By

Society for Immunotherapy of Cancer

Digital Subscription $4.99 Add to Cart
Print $9.95 Add to Cart
Free Sample

The digital subscription version of the Immunotherapy for Advanced Renal Cell Carcinoma GUIDELINES Pocket Guide contains all the same great information found in the physical pocket guide, and can be accessed on mobile devices and online:

  • Price: $4.99 per year
    • Subscribe to additional guideline titles for discounted rates
  • Includes automatic updates during the term of your subscription
  • CPT® and ICD10 codes can be added to certain guidelines for an additional fee
  • Supported platforms
    • iPhone and iPad
    • Android phones and tablets
    • Online (internet connection required)
  • Content on the Guideline Central mobile app accessible without an internet connection
    • Access to additional guideline summaries, clinical calculators, and more

For mobile access, download the free app from the App Store or Google Play and use the same email address and password as the website to login.

For individual use only; contact us for group and site licenses.

The Immunotherapy for the Treatment of Advanced Renal Cell Carcinoma Pocket Guide is based on the latest guidelines of the American Society of Clinical Oncology and was developed with their collaboration. It contains a management algorithm and graded recommendations for biomarker testing, immunotherapy approaches for all categories of renal cell carcinoma, adverse events, adjuvant therapy and quality of life.

  • Multifold
  • 10 Pages
  • 80# Diamond Silk Cover with Satin Aqueous Coating
  • 4.25″ x 7.25″
  • Key Points
  • Recommendations for:
    • First-Line Treatment of accRCC
    • Refractory accRCC
    • Adjuvant Therapy And Related Failures Within An IO-Related Treatment Paradigm For Patients With accRCC
    • Immune-Related Adverse Events Recognized And Managed In Patients With accRCC
    • Evaluate, Monitor and Manage Treatment Response To Immunotherapy In Patients With accRCC
    • Biomarker Testing In Patients With aRCC
    • Immunotherapy In Non-Clear Cell Pathology
    • Patients With accRCC Who Should Not Receive Immunotherapy
    • Quality of Life
  • Treatment Algorithm

The Society for Immunotherapy of Cancer (SITC) is the world's leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy.

  • Guideline Pricing

  • Single Title
    $4.99 / year
  • Any 5 Titles
    $23.99 / year
  • Any 10 Titles
    $41.99 / year
  • Any 35 Titles
    $74.99 / year
  • All Available Titles
    $169.99 / year

To get started, log in or create your free account Create Account